Eisai Co. Ltd.

In News

Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation | News ReleaseNews Release：2026 | Eisai Co., Ltd. - eisai.com

eisai.com - Mar 17, 2026

LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China - Biogen

Biogen - Sep 03, 2026

Eisai Co., Ltd. 2027 Q1 - Results - Earnings Call Presentation (OTCMKTS:ESAIY) 2026-08-03 - Seeking Alpha

Seeking Alpha - Aug 03, 2026

Eisai Co., Ltd. Revenue Breakdown – TSE:4523 - TradingView

TradingView - Jul 29, 2026

Eisai and Biogen Announce Canada’s Drug Agency Final Recommendation Supporting Public Reimbursement of LEQEMBI for Eligible Early Alzheimer’s Disease Patients - Quiver Quantitative

Quiver Quantitative - Aug 31, 2026

Eisai Selected for “SOMPO Sustainability Index” for FY2026 - eisai.com

eisai.com - Jul 06, 2026

FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - reuters.com

reuters.com - Jul 13, 2026

Earnings call transcript: Eisai Q1 2026 beats revenue forecast, stock slips 3.6% - Investing.com

Investing.com - Aug 03, 2026

Canada’s Drug Agency Issues Final Positive Recommendation - GlobeNewswire

GlobeNewswire - Aug 31, 2026

EISAI TO BEGIN ENROLLING PHASE 2 STUDY IN PATIENTS WITH NARCOLEPSY - PR Newswire

PR Newswire - Mar 26, 2026

LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment - Biogen

Biogen - Jul 14, 2026

Eisai strikes Japan licensing deal with Shanghai Henlius Biotech - reuters.com

reuters.com - Feb 05, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment